Literature DB >> 1521471

Localization of vasoactive intestinal peptide (VIP) messenger RNA (mRNA) in amacrine cells of rat retina.

S Okamoto1, H Okamura, H Terubayashi, Y Akagi, H Okamoto, Y Ibata.   

Abstract

We detected vasoactive intestinal peptide (VIP) messenger RNA (mRNA) in the rat retina using an in situ hybridization technique and a 35S-labelled cDNA probe. VIP mRNA was present in the cells of the inner nuclear layer (INL). The VIP mRNA-positive cells showed a distribution similar to that of the VIP-like immunoreactive amacrine cells. This observation suggests that VIP mRNA undergoes transcription in the VIP-immunoreactive amacrine cells.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1521471     DOI： 10.3109/02713689209000744

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN： 0271-3683            Impact factor:   2.424


  5 in total

1.  Spatiotemporal distribution of vasoactive intestinal polypeptide receptor 2 in mouse suprachiasmatic nucleus.

Authors:  Sungwon An; Connie Tsai; Julie Ronecker; Alison Bayly; Erik D Herzog
Journal:  J Comp Neurol       Date:  2012-08-15       Impact factor: 3.215

Review 2.  Control of complex behavior by astrocytes and microglia.

Authors:  P I Ortinski; K J Reissner; J Turner; T A Anderson; A Scimemi
Journal:  Neurosci Biobehav Rev       Date:  2022-04-01       Impact factor: 9.052

3.  Vasoactive intestinal peptide/peptide histidine isoleucine mRNA in the eye and suprachiasmatic nucleus of normal and monocularly enucleated rats.

Authors:  P Denis; M Dussaillant; J P Nordmann; A Bérod; H Saraux; W Rostène
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-09       Impact factor: 3.117

4.  Vasoactive intestinal polypeptide entrains circadian rhythms in astrocytes.

Authors:  Luciano Marpegan; Thomas J Krall; Erik D Herzog
Journal:  J Biol Rhythms       Date:  2009-04       Impact factor: 3.182

5.  The Neuropeptide Systems and their Potential Role in the Treatment of Mammalian Retinal Ischemia: A Developing Story.

Authors:  D Cervia; G Casini
Journal:  Curr Neuropharmacol       Date:  2013-01       Impact factor: 7.363
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.